Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Cardiology Reports
Erschienen in: Current Cardiology Reports 1/2015

01.01.2015 | Nuclear Cardiology (V Dilsizian, Section Editor)

Myocardial Viability in Coronary Artery Chronic Total Occlusion

verfasst von: Huseng Vefali, Yugandhar Manda, Jamshid Shirani

Erschienen in: Current Cardiology Reports | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Coronary artery chronic total occlusion (CTO) has rapidly become a popular target of percutaneous coronary intervention (PCI). Technical and technological advances required for approaching these anatomically complex and challenging lesions have progressed at an extraordinary pace and have led to amazing success rates. Patient selection, however, has primarily focused on patient symptoms, lesion characteristics, as well as the state of collateral circulation. Multiple national and international registries have been established to follow the progress of percutaneous CTO recanalization and have provided valuable information. Concern, however, exists that this challenging procedure will become the “standard of care” before its effectiveness and appropriateness is tested in prospective controlled trials. This manuscript reviews the current state of patient selection and the need for careful assessment of the presence and extent of myocardial viability prior to lengthy, resource-intensive, and potentially high-risk procedures.
Literatur
1.•
Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol. 2012;59:991–7. A landmark report providing in-depth information about the demographics, presenting symptoms, angiographic characteristics and approaches to management of patients with coronary chronic total occlusion. CrossRefPubMed
2.
Li R, Yang S, Tang L, et al. Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions. J Cardiothorac Surg. 2014;9:41.CrossRefPubMedCentralPubMed
3.
Tamburino C, Capranzano P, Capodanno D, et al. Percutaneous recanalization of chronic total occlusions: wherein lies the body of proof? Am Heart J. 2013;165:133–42.CrossRefPubMed
4.•
Yamamoto E, Natsuaki M, Morimoto T, et al. Long-term outcomes after percutaneous coronary intervention for chronic total occlusion (from the CREDO-Kyoto registry cohort-2). Am J Cardiol. 2013;112:767–74. An excellent contemporary prospective study of a large cohort of patients with chronic total occlusion managed invasively showing no improvement in 3-year mortality with successful percutaneous intervention. CrossRefPubMed
5.
Katsuragawa M, Fujiwara H, Miyamae M, Sasayama S. Histologic studies in percutaneous transluminal coronary angioplasty for chronic total occlusion: comparison of tapering and abrupt types of occlusion and short and long occluded segments. J Am Coll Cardiol. 1993;21:604–11.CrossRefPubMed
6.
Srivatsa SS, Edwards WD, Boos CM, et al. Histologic correlates of angiographic chronic total coronary artery occlusions: influence of occlusion duration on neovascular channel patterns and intimal plaque composition. J Am Coll Cardiol. 1997;29:955–63.CrossRefPubMed
7.•
Sakakura K, Nakano M, Otsuka F, et al. Comparison of pathology of chronic total occlusion with and without coronary artery bypass graft. Eur Heart J. 2014;35:1683–93. An in-depth analysis of the histopathologic features of coronary artery segments with chronic total occlusion including characteristics of the proximal and distal caps, plaque composition and degree of calcification. CrossRefPubMed
8.
Godino C, Carlino M, Al-Lamee R, Colombo A. Coronary chronic total occlusion. Minerva Cardioangiol. 2010;58:41–60.PubMed
9.
Singh M, Bell MR, Berger PB, Holmes Jr DR. Utility of bilateral coronary injections during complex coronary angioplasty. J Invasive Cardiol. 1999;11:70–4.PubMed
10.
Mollet NR, Hoye A, Lemos PA, et al. Value of preprocedure multislice computed tomographic coronary angiography to predict the outcome of percutaneous recanalization of chronic total occlusions. Am J Cardiol. 2005;95:240–3.CrossRefPubMed
11.
Li P, Gai L, Yang X, et al. Computed tomography angiography-guided percutaneous coronary intervention in chronic total occlusion. J Zhejiang Univ Sci B. 2010;11:568–74.CrossRefPubMedCentralPubMed
12.
Choi JH, Song YB, Hahn JY, et al. Three dimensional quantitative volumetry of chronic total occlusion plaque using coronary multidetector computed tomography. Circ J. 2011;75:366–75.CrossRefPubMed
13.
Lehman SJ, Schlett CL, Bamberg F, et al. Appearance of acute and chronic coronary occlusions in contrast-enhanced cardiac computed tomography. JACC Cardiovasc Imaging. 2008;1:809–11.CrossRefPubMed
14.
Ehara M, Terashima M, Kawai M, et al. Impact of multislice computed tomography to estimate difficulty in wire crossing in percutaneous coronary intervention for chronic total occlusion. J Invasive Cardiol. 2009;21:575–82.PubMed
15.•
Li M, Zhang J, Pan J, Lu Z. Coronary total occlusion lesions: linear intrathrombus enhancement at CT predicts better outcome of percutaneous coronary intervention. Radiology. 2013;266:443–51. An interesting and provocative study correlating computed tomographic correlates of intra-lesional channels with potential success of percutaneous recanalization of chronically occluded coronary lesions. CrossRefPubMed
16.
Rolf A, Werner GS, Schuhback A, et al. Preprocedural coronary CT angiography significantly improves success rates of PCI for chronic total occlusion. Int J Cardiovasc Imaging. 2013;29:1819–27.CrossRefPubMed
17.
Michael TT, Karmpaliotis D, Brilakis ES, et al. Procedural outcomes of revascularization of chronic total occlusion of native coronary arteries (from a multicenter United States registry). Am J Cardiol. 2013;112:488–92.CrossRefPubMed
18.
Christopoulos G, Menon RV, Karmpaliotis D, et al. Application of the “hybrid approach” to chronic total occlusions in patients with previous coronary artery bypass graft surgery (from a contemporary multicenter US registry). Am J Cardiol. 2014;113:1990–4.CrossRefPubMed
19.
Kim BK, Shin S, Shin DH, et al. Clinical outcome of successful percutaneous coronary intervention for chronic total occlusion: results from the multicenter Korean chronic total occlusion (K-CTO) registry. J Invasive Cardiol. 2014;26:255–9.PubMed
20.
Chung CM, Nakamura S, Tanaka K, et al. Effect of recanalization of chronic total occlusions on global and regional left ventricular function in patients with or without previous myocardial infarction. Catheter Cardiovasc Interv. 2003;60:368–74.CrossRefPubMed
21.
Baks T, van Geuns RJ, Duncker DJ, et al. Prediction of left ventricular function after drug-eluting stent implantation for chronic total coronary occlusions. J Am Coll Cardiol. 2006;47:721–5.CrossRefPubMed
22.
Kirschbaum SW, Baks T, van den Ent M, et al. Evaluation of left ventricular function three years after percutaneous recanalization of chronic total coronary occlusions. Am J Cardiol. 2008;101:179–85.CrossRefPubMed
23.
Sirnes PA, Myreng Y, Mølstad P, et al. Improvement in left ventricular ejection fraction and wall motion after successful recanalization of chronic coronary occlusions. Eur Heart J. 1998;19:273–81.CrossRefPubMed
24.
Werner GS, Surber R, Kuethe F, et al. Collaterals and the recovery of left ventricular function after recanalization of a chronic total coronary occlusion. Am Heart J. 2005;149:129–37.CrossRefPubMed
25.
Brilakis ES, Karmpaliotis D, Patel V, Banerjee S. Complications of chronic total occlusion angioplasty. Interv Cardiol Clin. 2012;1:373–89.
26.
Patel VG, Brayton KM, Tamayo A, et al. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv. 2013;6:128–36.CrossRefPubMed
27.
Patel Y, Depta JP, DeMartini TJ. Complications of chronic total occlusion percutaneous coronary intervention. Interv Cardiol. 2013;5:567–75.CrossRef
28.•
Lo N, Michael TT, Moin D, et al. Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study. JACC Cardiovasc Interv. 2014;7:47–54. A study of 325 consecutive patients undergoing percutaneous intervention for chronic total occlusion demonstrating the impact of periprocedural myocardial injury on mid-term outcomes. CrossRefPubMedCentralPubMed
29.
Paizis I, Manginas A, Voudris V, et al. Percutaneous coronary intervention for chronic total occlusions: the role of side-branch obstruction. EuroIntervention. 2009;4:600–6.CrossRefPubMed
30.
Zimarino M, Ausiello A, Contegiacomo G, et al. Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions. J Am Coll Cardiol. 2006;48:59–65.CrossRefPubMed
31.
Meier P, Indermuehle A, Pitt B, et al. Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis. BMC Med. 2012;10:62.CrossRefPubMedCentralPubMed
32.
Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985;5:587–92.CrossRefPubMed
33.
Werner GS, Ferrari M, Heinke S, et al. Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions. Circulation. 2003;107:1972–7.CrossRefPubMed
34.
Werner GS, Surber R, Ferrari M, et al. The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction. Eur Heart J. 2006;27:2406–12.CrossRefPubMed
35.
Di Carli M, Sherman T, Khanna S, et al. Myocardial viability in asynergic regions subtended by occluded coronary arteries: relation to the status of collateral flow in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23:860–8.CrossRefPubMed
36.
Muehling O, Jerosch-Herold M, Cyran C, et al. Assessment of collateralized myocardium with cardiac magnetic resonance (CMR): transmural extent of infarction but not angiographic collateral vessel filling determines regional function and perfusion in collateral-dependent myocardium. Int J Cardiol. 2007;120:38–44.CrossRefPubMed
37.
He ZX, Mahmarian JJ, Verani MS. Myocardial perfusion in patients with total occlusion of a single coronary artery with and without collateral circulation. J Nucl Cardiol. 2001;8:452–7.CrossRefPubMed
38.
Arani DT, Greene DG, Bunnell IL, et al. Reductions in coronary flow under resting conditions in collateral-dependent myocardium of patients with complete occlusion of the left anterior descending coronary artery. J Am Coll Cardiol. 1984;3:668–74.CrossRefPubMed
39.
Aboul-Enein F, Kar S, Hayes SW, et al. Influence of angiographic collateral circulation on myocardial perfusion in patients with chronic total occlusion of a single coronary artery and no prior myocardial infarction. J Nucl Med. 2004;45:950–5.PubMed
40.
Shirani J, Pranesh S, Menhaji K, et al. Dobutamine-induced myocardial ischemia and ST-segment elevation in collateral-dependent myocardium. Am J Cardiol. 2013;112:1293–7.CrossRefPubMed
41.
Choi JH, Chang SA, Choi JO, et al. Frequency of myocardial infarction and its relationship to angiographic collateral flow in territories supplied by chronically occluded coronary arteries. Circulation. 2013;127:703–9.CrossRefPubMed
42.
Zhang J, Li Y, Li M, et al. Collateral vessel opacification with CT in patients with coronary total occlusion and its relationship with downstream myocardial infarction. Radiology. 2014;271:703–10.CrossRefPubMed
43.
Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–16.CrossRefPubMed
44.
Chaitman BR, Hardison RM, Adler D, et al. The bypass angioplasty revascularization investigation 2 diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation. 2009;120:2529–40.CrossRefPubMedCentralPubMed
45.
Hochman JS, Reynolds HR, Dzavík V, et al. Long-term effects of percutaneous coronary intervention of the totally occluded infarct related artery in the subacute phase after myocardial infarction. Circulation. 2011;124:2320–8.CrossRefPubMedCentralPubMed
46.
Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364:1607–16.CrossRefPubMedCentralPubMed
47.
Meijboom WB, Mieghem CA, Pelt N, et al. Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography vs conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina. J Am Coll Cardiol. 2008;52:636–43.CrossRefPubMed
48.
Aldweib N, Negishi K, Hachamovitch R, et al. Impact of repeat myocardial revascularization on outcome in patients with silent ischemia after previous revascularization. J Am Coll Cardiol. 2013;61:1616–23.CrossRefPubMed
49.
Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283–91.CrossRefPubMed
50.
Lee SW, Lee JY, Park DW, et al. Long-term clinical outcomes of successful versus unsuccessful revascularization with drug-eluting stents for true chronic total occlusion. Catheter Cardiovasc Interv. 2011;78:346–53.PubMed
51.
Udelson JE, Pearte CA, Kimmelstiel CD, et al. The occluded artery trial (OAT) viability ancillary study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone. Am Heart J. 2011;161:611–21.CrossRefPubMedCentralPubMed
52.•
Safley DM, Koshy S, Grantham JA, et al. Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions. Catheter Cardiovasc Interv. 2011;78:337–43. A study of 301 patients with successful percutaneous intervention of chronic total occlusion demonstrating the significance of a quantitative approach to assessment of pre-procedural ischemic burden. Patients with an ischemic burden of >12.5 % had the highest likelihood of significant decrease in ischemic burden post-procedurally. PubMed
53.
Danchin N, Angidi M, Cador R, et al. Effect of late percutaneous angioplastic recanalization of total corona artery occlusion on left ventricular remodeling, ejection fraction, and regional wall motion. Am J Cardiol. 1996;78:729–35.CrossRefPubMed
54.
Locca D, Bucciarelli-Ducci C, Ferrante G, et al. Left ventricular ejection function and viability assessed by CMR in patients undergoing anterograde versus retrograde percutaneous coronary interventions for chronic total occlusion: a Ppe and post procedure study. J Cardiovasc Magn Reson. 2008;10 Suppl 1:A283.CrossRef
55.
Pavlovic SV, Sobic-Saranovica DP, Beleslinb BD, et al. One-year follow-up of myocardial perfusion and function evaluated by gated SPECT MIBI in patients with earlier myocardial infarction and chronic total occlusion. Nucl Med Commun. 2009;30:68–75.CrossRefPubMed
56.
Fiocchi F, Sgura F, Di Girolamo A, et al. Chronic total coronary occlusion in patients with intermediate viability: value of low-dose dobutamine and contrast-enhanced 3-T MRI in predicting functional recovery in patients undergoing percutaneous revascularisation with drug-eluting stent. Radiol Med. 2009;114:692–704.CrossRefPubMed
57.
Paul GA, Connelly K, Zia M, et al. Impact of percutaneous coronary intervention of chronic total occlusion on left ventricular function using cardiac magnetic resonance imaging. J Cardiovasc Magn Reson. 2011;13 Suppl 1:M6.CrossRefPubMedCentral
58.
Yue WW, Huangfu FT, Yin J, Wang T, Wang GF, Jia RY. Assessment of recanalization of chronic total occlusions on left ventricular function in patients with or without previous myocardial infarction by real-time three-dimensional echocardiography. Cell Biochem Biophys. 2012;62:83–6.CrossRefPubMed
59.
Sun D, Wang J, Tian Y, et al. Multimodality imaging evaluation of functional and clinical benefits of percutaneous coronary intervention in patients with chronic total occlusion lesion. Theranostics. 2012;2:788–800.CrossRefPubMedCentralPubMed
60.•
Kirschbaum SW, Rossi A, Boersma E, et al. Combining magnetic resonance viability variables better predicts improvement of myocardial function prior to percutaneous coronary intervention. Int J Cardiol. 2012;159:192–7. A prospective study of 72 patients demonstrating the significance of a multi-parametric approach to myocardial viability assessment in patients with coronary chronic total occlusion. CrossRefPubMed
61.
Galiuto L, Barchetta S, Fedele E, et al. Effects of late REopening of coronary total occlusion on micRovascular perfusion and myocarDial function: the RECORD study. Eur Heart J - Cardiovasc Imaging. 2013;14:487–94.CrossRefPubMed
62.
Erdogan E, Akkaya M, Bacaksiz A, et al. Early assessment of percutaneous coronary interventions for chronic total occlusions analyzed by novel echocardiographic techniques. Clinics. 2013;68:1333–7.CrossRefPubMedCentralPubMed
63.
Pujadas S, Martin V, Rosselló X, et al. Improvement of myocardial function and perfusion after successful percutaneous revascularization in patients with chronic total coronary occlusion. Int J Cardiol. 2013;169:147–52.CrossRefPubMed
64.
Cheng AS, Selvanayagam JB, Jerosch-Herold M, et al. Percutaneous treatment of chronic total coronary occlusions improves regional hyperemic myocardial blood flow and contractility: insights from quantitative cardiovascular magnetic resonance imaging. JACC Cardiovasc Interv. 2008;1:44–53.CrossRefPubMed
65.
Petronio AS, Baglini R, Limbruno U, et al. Coronary collateral circulation behaviour and myocardial viability in chronic total occlusion treated with coronary angioplasty. Eur Heart J. 1998;19:1681–7.CrossRefPubMed
66.
Kumbasar D, Akyürek O, Dincer I, et al. Good collaterals predict viable myocardium. Angiology. 2007;58:550–5.CrossRefPubMed
67.
Chammas E, Hussein A, Ballane G, et al. Myocardial perfusion in patients with a totally occluded left anterior descending coronary artery reinjected by a normal right coronary artery: the role of collateral circulation. Angiology. 2008;59:464–8.CrossRefPubMed
68.
Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation. 2011;124:e574–651.CrossRefPubMed
69.
Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2010;31:2501–55.CrossRefPubMed
Metadaten
Titel
Myocardial Viability in Coronary Artery Chronic Total Occlusion
verfasst von
Huseng Vefali
Yugandhar Manda
Jamshid Shirani
Publikationsdatum
01.01.2015
Verlag
Springer US
Erschienen in
Current Cardiology Reports / Ausgabe 1/2015
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-014-0552-x

Weitere Artikel der Ausgabe 1/2015

Current Cardiology Reports 1/2015 Zur Ausgabe

Nuclear Cardiology (V Dilsizian, Section Editor)

Longitudinal Myocardial Blood Flow Gradient and CAD Detection

Nuclear Cardiology (V Dilsizian, Section Editor)

Effective Risk Stratification of Patients on the Basis of Myocardial Perfusion SPECT Is Dependent on Appropriate Patient Selection

Nuclear Cardiology (V Dilsizian, Section Editor)

FDG PET Imaging for Identifying Pulmonary Hypertension and Right Heart Failure

Ischemic Heart Disease (D Mukherjee, Section Editor)

Cardiovascular Adverse Events Associated with Smoking-Cessation Pharmacotherapies

Neu im Fachgebiet Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise